The use of gadolinium-based contrast agents should be discontinued until proven safe.
Sign Up to like & getrecommendations! Published in 2017 at "Medical physics"
DOI: 10.1002/mp.12212
Abstract: Gadolinium-based contrast agents (GBCAs) are widely used in MRI to increase the visibility of tissues. Some believe, however, that due to their documented toxicity, clinical use of these agents should be discontinued until proven safe.… read more here.
Keywords: contrast agents; discontinued proven; proven safe; gadolinium based ... See more keywords